The Norwalk and Hawaii viruses are antigenically distinct members of the family Caliciviridae and are considered to be important etiologic agents of epidemic gastroenteritis, with most studies focusing on the role of Norwalk virus. To further investigate the importance of Hawaii virus, Hawaii virus-like particles (VLPs) were produced by expression of its capsid protein in the baculovirus system and these VLPs were used as the antigen in an enzyme-linked immunosorbent assay that was efficient in the detection of a serologic response to Hawaii virus. The ready availability of Hawaii VLPs should enable larger-scale epidemiological studies to further elucidate the importance of this agent.
Norwalk virus (NV) and NV-like viruses are small, noncultivatable viruses in the family Caliciviridae that are major etiologic agents of epidemic gastroenteritis in adults and older children (17) . The NV-like human caliciviruses are comprised of at least four distinct serotypes represented by NV, Hawaii virus (HV), Snow Mountain virus (SMV), and Taunton virus, which have been defined by immune electron microscopy (IEM). HV was recovered from a family outbreak of gastroenteritis (29) . Cross-challenge studies in adult volunteers, with NV and HV, as well as serologic studies by IEM, have established that these two viruses are antigenically distinct (5, 15, 32) . In addition, such volunteer studies have generated important reference reagents for the NV and HV strains that have been used to establish the specificity of new recombinantprotein-based diagnostic assays in the absence of a cell culture system (8, 13, 14, 26, 30) . Recent sequence comparisons of the RNA-dependent RNA polymerase (64% amino acid identity) and capsid-encoding (48% amino acid identity) regions of the genomes of NV and HV were consistent with the antigenic differences observed in earlier studies (22) . In addition, by sequence analysis of various circulating strains, the human caliciviruses associated with epidemic gastroenteritis have been assigned to either genogroup I (NV related) or genogroup II (SMV or HV related) (reviewed in reference 20) . A third genetically distinct group of human caliciviruses represented by the Sapporo and Manchester viruses has also been described (20) . However, the full extent of the genetic and antigenic diversity among the human viruses in the family Caliciviridae has not been elucidated.
The epidemiology of NV is the most thoroughly investigated of the human caliciviruses (17) . Early studies that established the association of NV with epidemic gastroenteritis employed diagnostic assays that relied on viral antigens present in stool specimens obtained from volunteers infected with NV (9, 10) . The recent molecular characterization of NV (12) and other human calicivirus (4, 19, 25) genomes has facilitated the development of recombinant DNA-based diagnostic techniques (4, 13, 14, 24) . Expression of the capsid protein of NV in the baculovirus system resulted in the production of recombinant NV (rNV) virus-like particles (VLPs) that were similar in efficiency, sensitivity, and specificity to native NV for the detection of serologic responses to NV by both enzyme-linked immunosorbent assay (ELISA) and IEM (8, 13, 26, 30) . The availability of an unlimited supply of recombinant antigen for the detection of serological responses to NV has enabled recent large-scale epidemiologic studies that have confirmed the role of NV in gastrointestinal illness in various settings (7, 11, 28) . The purpose of our present study was to develop HVspecific diagnostic assays to elucidate the role of HV or HVrelated viruses in gastrointestinal disease.
A cDNA copy of ORF2, encoding the capsid protein of HV (HCV/Hawaii/71/U.S.), was generated in a first-round reverse transcription-PCR using a viral RNA template extracted from the stool specimen of an adult volunteer as previously described (22) . A second PCR that utilized primers 5ЈGGATCC GTTTTGTGAATGAAGATG3Ј (the 5Ј end of ORF2 and a BamHI restriction enzyme site) and 5ЈGCGGCCGCATTAC TGCACTCTTCT3Ј (complementary to the 3Ј end of ORF2 with a NotI restriction enzyme site) was used to generate an approximately 1,600-bp fragment that was cloned into plasmid pCRII by using the TA system (Invitrogen). The resulting plasmid (designated pCRII-HVORF2) was digested with BamHI and NotI, and the ORF2 DNA fragment was purified from an agarose gel and ligated into the compatible sites of the pVL1393 transfer plasmid (Invitrogen) downstream from the baculovirus polyhedrin promoter. Plasmid pVL1393-HVORF2 was cotransfected with linearized baculovirus DNA (BaculoGold; Pharmingen) into Sf9 cells. Recombinant viruses were amplified and screened for the production of VLPs by direct electron microscopy, and selected positive recombinant viruses were plaque purified twice. For production of recombinant HV (rHV) VLPs, recombinant baculoviruses were inoculated onto Sf9 monolayers at a multiplicity of infection of 5 to 10 and particles were purified in 10 to 50% sucrose gradients from the culture fluid of infected cells. VLPs obtained by expression of the HV capsid protein in the baculovirus system were morphologically similar to previously described NV VLPs (13) (Fig. 1) . By negative-stain electron microscopy, numerous approximately 27-to 35-nm particles were observed, some of which appeared empty and others of which appeared full. Subviralsize (approximately 20-nm) particles (not shown) were also observed variably. Hyperimmune sera specific for the rHV VLPs were generated by immunization of guinea pigs with purified VLPs by using standard protocols, and these sera reacted with the rHV protein by ELISA and Western blotting (data not shown).
The rHV VLPs were used as an antigen in the development of an ELISA that was performed in a format similar to that previously described by Jiang et al. for rNV (13) . Briefly, purified rHV VLPs were diluted in phosphate-buffered saline and adsorbed to the wells (1 g/well) of a polyvinyl microtiter plate by incubation overnight at 4°C. Following blocking of nonspecific binding sites on the plate with 5% BLOTTO (nonfat dry milk in phosphate-buffered saline), serial twofold dilutions of each serum sample were made at a starting dilution of 1:50. The binding of antibodies to the rHV antigen was detected with peroxidase-conjugated goat anti-human antibody (Cappel) and 2,2Ј-azinobis(3-ethylbenzthiazolinesulfonic acid) (ABTS) substrate. Titers were reported as the reciprocal of the highest dilution that met the definition for a positive reaction with the rHV antigen (an optical density at 405 nm of Ն0.200). A significant serologic response was defined as a fourfold or greater increase in the titer of the antibody to the recombinant antigen between preinfection or acute-phase and postinfection sera. Paired sera from an individual were tested simultaneously in duplicate wells. A rNV ELISA (13) was used to detect antibodies to NV by using reagents kindly provided by Mary Estes, Baylor College of Medicine, Houston, Tex.
Paired preinfection or acute-phase and postinfection sera from selected HV, NV, or NV-related virus studies were evaluated for antibodies to rHV to establish the specificity of the rHV ELISA as follows: (i) five adult volunteers who had developed gastrointestinal illness following oral administration of FIG. 1. Purified HV-like particles expressed in the baculovirus system and visualized by negative staining with 3% phosphotungstic acid, pH 7.2. Bar, 100 nm.
HV (32) ( Table 1) ; (ii) three chimpanzees that were challenged with NV by the alimentary route and developed antibody responses to native NV by IEM and to rNV as previously reported (8, 33) , (no. 1 to 3 in Table 2 ); (iii) two adult volunteers challenged orally with the Montgomery County agent, a virus antigenically related to NV (15, 29) (no. 4 and 5 in Table  2 ); and (iv) a member of the U.S. military infected under natural conditions with the Desert Shield strain (HCV-DSV395/90/Saudi Arabia), a virus belonging to NV-related genogroup I (21) (no. 6 in Table 2 ). Thus, the rHV ELISA detected evidence of infection with native HV efficiently but did not detect evidence of infection with NV or NV-related virus. These findings were consistent with previous reports that the rNV ELISA did not efficiently detect serologic evidence of infection in volunteers challenged with HV (8, 30) .
The specificity of the rHV ELISA was also evaluated by using paired sera from adult volunteers who underwent oral challenge with SMV strain HCV/SMV/76/U.S., a reference strain that has been identified as antigenically distinct from NV and HV by IEM and belonging to genogroup II (as does HV) by sequence analysis of the polymerase region (6, 31) . The polymerase region of the SMV genome shares 59 and 92% amino acid identity with NV and HV, respectively (22, 31) . Four of five adult volunteers challenged with SMV and previously shown to develop a serologic response to this virus in a blocking antibody immunoassay (BAI) (26) failed to develop a serologic response to either rHV or rNV by ELISA (no. 7 to 10 in Table 2 ). The characteristic inefficiency of the rHV ELISA in detecting significant antibody responses to SMV was consistent with the identification of HV and SMV as distinct serotypes by IEM and suggests that a strong genetic relatedness in the polymerase region does not necessarily reflect antigenic relatedness in the capsid protein. However, one individual (no. 11 in Table 2 ) infected with SMV developed a serologic response to both rHV and rNV. In addition, a pediatric patient in a Canadian hospital undergoing natural infection with the Toronto 19 strain (HCV/TV19/90/CAN), belonging to genogroup II (23), showed a serologic response to both rNV and rHV (no. 12 in Table 2 ). The cross-reactive responses to both NV and HV observed in individuals 11 and 12 in Table 2 are of interest because each of them underwent infection with viruses that have been genetically characterized as belonging to genogroup II. It is not known whether these cross-reactive responses reflect evidence of prior calicivirus infection in these individuals or the current infection. These occasional broad antibody responses indicate that the analysis of paired sera from individuals undergoing natural infection with circulating viruses must be interpreted with caution in regard to the antigenic specificity of the infecting strain.
The relationship of the rHV was examined with paired sera derived from three other well-characterized gastroenteritis outbreaks that were not associated with NV in previous studies. Four adult volunteers who were orally administered the Wollan or W agent (16) , which was associated with a gastroenteritis outbreak in an English boarding school (3), and who developed illness following the challenge were examined for serologic responses to the rHV. Two of the four developed a serologic response to rHV by ELISA, whereas none of them developed a response to rNV or to NV in each of the three tested by IEM (no. 13 to 16 in Table 2 ) (16) . Paired sera from four individuals involved in the Henryton II and Morgantown, W.Va., outbreaks (1, 2) were examined (no. 17 to 20 in Table  2 ). An agent(s) associated with the Morgantown, W.Va., outbreak could not be identified in this serologic analysis. However, it is possible that the Wollan and Henryton II outbreaks were caused by a human calicivirus. Further characterization of these viruses is needed to address this possibility.
Serologic responses to rHV were examined in 223 individuals involved in 23 outbreaks of nonbacterial gastroenteritis that were not associated with NV in a previous study (27) . Twentythree (10.3%) of the individuals examined showed a fourfold or greater increase in antibody to HV (Table 3) , and as previously reported (27) , only 3 (1.4%) of 207 developed a serologic response to NV in the NV BAI ELISA. Two of the outbreaks met the definition for an HV outbreak established previously, i.e., 50% or more of the affected individuals showed a serologic response to the assayed agent (9, 18) . Furthermore, 14 (61%) of these 23 outbreaks included one or more individuals who developed a serologic response to rHV, suggesting that a human calicivirus distinct from both NV and HV may have been the primary cause of illness in these outbreaks. As assays become available for other antigenically distinct human caliciviruses, the identification of caliciviruses as etiologic agents of epidemic gastroenteritis will undoubtedly increase.
NV has been established as a cause of nonbacterial epidemic gastroenteritis, but few studies have examined the role of HV. Expression of ORF2 of HV in the baculovirus system resulted in the production of VLPs that were antigenically indistinguishable from native HV, and these VLPs were used in the development of an ELISA for the detection of HV-specific antibodies. Moreover, a dissociation of serologic responses to NV and HV was observed when paired sera from challenge studies were analyzed, consistent with the major antigenic differences between these two viruses that had been established in cross-challenge studies and by IEM. The extent of antigenic variation among circulating human calicivirus strains associated with epidemic gastroenteritis is an important characteristic of these viruses that is relevant for an understanding of their epidemiology and natural history. Several classification systems for human calicivirus serotypes have been proposed, but the limited quantities of reference stool specimens containing the native virus have impeded the development of standardized reagents. The availability of recombinant VLPs for major reference strains such as NV and HV, the first two distinct serotypes described, should facilitate the development of such reagents. (27) , who used the NV BAI, an assay that employed NV antigen in stool and is similar in efficiency and specificity to the rNV ELISA (8) .
b Data in boldface indicate an outbreak in which Ն50% of the individuals developed a serologic response to the assayed virus.
